Connect with us

News

Johnson & Johnson Vaccine Should be Paused in U.S. After ‘Extremely Rare’ Blood Clots, FDA and CDC Say

Published

on

Johnson and Johnson vaccine

Federal health agencies on Tuesday recommended pausing the use of the Johnson & Johnson vaccine after a small number of people experienced “a rare and severe type of blood clot” after receiving the shot.

The Food and Drug Administration and the Centers for Disease Control and Prevention issued a statement saying they were “recommending a pause in the use of this vaccine out of an abundance of caution.”

Some 6.8 million people have received the single-shot vaccine in the United States. Of these, six have experienced the clot, the agencies said, adding: “Right now, these adverse events appear to be extremely rare.”

“The CDC and the FDA are taking these concerns about blood clots and the J&J vaccine seriously and are diligently assembling data,” the official said.

An expert outside the government who is familiar with the situation agreed that health officials are taking the matter seriously.

“The CDC is very concerned and they’re very working hard on this and monitoring this closely,” said the expert, who spoke on the condition of anonymity due to the sensitive nature of the issue.

There have been “four serious cases of unusual blood clots” reported after people received the Johnson & Johnson vaccine, according to European health authorities. Like their US counterparts, the European authorities say they’re still investigating these cases and that “it is currently not clear” whether there’s a causal association between the vaccine and the clots.

The concern in the United States isn’t just about the Johnson & Johnson shot per se. At a time when US health officials are encouraging Americans to get vaccinated as soon as they can, there’s a worry that news coverage about clots being studied in relation to Johnson & Johnson’s vaccine might make some Americans more hesitant to get any Covid-19 vaccine.

Vaccine hesitancy is already an issue in the US, and officials at the US Centers for Disease Control and Prevention and the US Food and Drug Administration are “thinking through how to communicate about the issue without creating the impression that something might be wrong with the [Johnson & Johnson] vaccine,” the federal health official said.

Another expert familiar with the situation said that was the right approach, stressing the importance of communicating without scaring people.

“I would hope that HHS is having a confab about this right now,” the expert said, referring to the US Department of Health and Human Services.

In a statement, Johnson & Johnson said its tracking of side effects revealed “a small number of very rare events following vaccination. At present, no clear causal relationship has been established between these rare events and the [Johnson & Johson] COVID-19 vaccine.”

The FDA released a statement last week that it was aware of reports of “serious thromboembolic events” in the US that occurred “in a few individuals following receipt of the [Johnson & Johnson] COVID-19 vaccine” and that “at this time we have not found a causal relationship with vaccination.”

Is the CEO/Founder of Investors King Limited. A proven foreign exchange research analyst and a published author on Yahoo Finance, Businessinsider, Nasdaq, Entrepreneur.com, Investorplace, and many more. He has over two decades of experience in global financial markets.

Continue Reading
Comments

Education

JAMB Releases 36,540 Withheld UTME Results, Dismisses Cyber Breach Claims

Published

on

The Joint Admission and Matriculation Board (JAMB) has quelled concerns over the integrity of the Unified Tertiary Matriculation Examination (UTME) results by releasing an additional 36,540 previously withheld scores.

This move follows earlier revelations of withheld results and assertions of a cyber security breach.

Fabian Benjamin, the spokesperson for JAMB, confirmed the release of these results in a statement issued late Tuesday in Abuja.

This latest batch of released scores, when combined with the 531 previously unveiled, brings the total number of results made public to 1,879,437.

Benjamin took the opportunity to address circulating rumors regarding the security of the UTME results.

He categorically dismissed claims of a cyber security breach, saying that the examination outcomes remain intact and securely stored.

He stressed that the results are not stored in any cloud system and thus cannot be compromised by external entities.

At the time of the UTME release, JAMB had disclosed that certain results were withheld pending further investigation.

Subsequently, 531 of these results were recently unveiled with the remainder still under scrutiny.

Benjamin explained that any candidates implicated in examination malpractice are undergoing thorough investigation.

The examination board intends to meticulously review footage from CCTV cameras installed across all accredited centers to ascertain each candidate’s involvement.

Benjamin urged the public to remain vigilant against misinformation originating from sources not affiliated with JAMB.

He attributed the discrepancies in minimum admissible scores to variations among tertiary institutions. Some institutions, he noted, proposed lower minimum scores than others, resulting in varying benchmarks.

Benjamin clarified that these benchmarks are determined collectively by all Heads of Institutions during the annual Policy Meeting on Admissions, ensuring uniformity across the country.

Also, Benjamin cautioned religious organizations against overstepping their designated roles.

He warned against the dissemination of false information to governmental bodies for personal gain.

Continue Reading

Travel

British Airways Owner IAG Prepares for Summer Surge Amid High Travel Demand

Published

on

british-airways

As the world gradually emerges from the grip of the pandemic, the travel industry is witnessing a resurgence in demand with British Airways owner IAG SA gearing up for a busy summer season.

Despite lingering challenges, the airline conglomerate remains optimistic about the outlook, citing strong demand for travel within Europe and across the Atlantic.

In a recent stock exchange filing, IAG disclosed an adjusted operating profit of €68 million ($73.3 million) for the three months ending March.

According to Chief Executive Officer Luis Gallego, the group’s core markets, including the North Atlantic, South Atlantic, and intra-Europe routes, have shown robust performance, positioning them well for the upcoming peak travel period.

With vaccination rates increasing and travel restrictions easing in many parts of the world, consumers are eager to resume travel plans, fueling the surge in demand.

However, the road ahead is not without its challenges. While travel within Europe and across the Atlantic remains strong, other regions present a more complex operating environment.

The ongoing conflict in the Middle East has dampened demand for certain destinations, while airspace restrictions resulting from geopolitical tensions, such as the Russian invasion of Ukraine, have disrupted flight routes to East Asia.

Despite these hurdles, IAG remains resilient, banking on the strength of its core markets and the performance of its brands to weather the storm.

The company’s strategic positioning and proactive measures to adapt to changing circumstances have positioned it to capitalize on the rebound in travel demand.

As the summer season approaches, IAG is focused on ensuring operational readiness to meet the surge in passenger numbers.

With travelers eager to reconnect with loved ones, explore new destinations, and embark on long-awaited vacations, the airline group stands ready to facilitate safe and seamless travel experiences.

As vaccination campaigns progress and travel sentiment rebounds, IAG’s proactive approach and strategic investments position it as a key player in the aviation industry’s recovery journey. With optimism on the horizon, the company remains committed to delivering exceptional service and fostering a seamless travel experience for passengers worldwide.

Continue Reading

News

Israeli Troops Take Control of Rafah Border Crossing Amidst Ceasefire Talks

Published

on

Israeli troops took control of the Rafah border-crossing area in Gaza on Tuesday morning, with Hamas saying all aid flows from Egypt had stopped.

The army has halted “the movement of people and aid completely,” the Hamas-run crossing authority said in a statement. Soldiers replaced Palestinian flags with Israeli ones.

It’s the first time Israel’s army has moved into the area since the war with Hamas began in October.

Israeli Military Tells About 100,000 People to Leave Eastern Rafah

Palestinians sheltering in Rafah were told Monday to move to an “expanded humanitarian area”.

The border is the main entry point for aid into Gaza, and the Palestinian territory’s only crossing aside from those with Israel. The US has been urging Israel for weeks to allow more food and other supplies into Gaza, parts of which the United Nations says are on the verge of famine.

The movement of troops came a day after Israel told residents in parts of eastern Rafah to leave immediately ahead of a possible attack on the city.

Most Arab and many European states have said Israel should not attack Rafah, fearing it would cause mass casualties. Prime Minister Benjamin Netanyahu says Rafah is the last bastion of Hamas, with about 5,000 to 8,000 of its fighters and senior leaders lodged in the city, as well as many Israeli hostages.

Cease-fire talks between the two sides continue to drag. Hamas said on Monday night it had accepted a proposal from mediators Egypt and Qatar. Israel rejected it, saying it contained demands the Jewish state cannot accept.

Continue Reading
Advertisement




Advertisement
Advertisement
Advertisement

Trending